<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662554</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-55884</org_study_id>
    <secondary_id>ENT0080</secondary_id>
    <nct_id>NCT04662554</nct_id>
  </id_info>
  <brief_title>Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging</brief_title>
  <official_title>Pilot Study of a 1-Millimeter Resolution Clinical PET System in Head and Neck Cancer Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Goldman Sachs Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wallace H. Coulter Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emerson Collective</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain initial experience imaging HNC patient using a new PET&#xD;
      camera, a 1mm spacial resolution. The goal is to understand image quality of the system and&#xD;
      to see how it works in a clinical environment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE(S): Gain initial experience imaging head/neck cancer patients using a novel&#xD;
      PET camera comprising two opposing panels with 1 millimeter spatial resolution.&#xD;
&#xD;
      SECONDARY OBJECTIVE(S):&#xD;
&#xD;
        1. Determine the radioactive dose and scan time required for this novel 1 millimeter (mm)&#xD;
           resolution clinical PET camera.&#xD;
&#xD;
        2. Images obtained with the 1 mm resolution PET camera will be compared to conventional PET&#xD;
           imaging (which will serve as gold standard) for image quality and lesion/node&#xD;
           visualization.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2022</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acquiring PET images of HNC patients with the 1 mm resolution PET imaging device.</measure>
    <time_frame>Day 1</time_frame>
    <description>PET images of HNC patients with the 1 mm resolution PET imaging device will be qualitatively accessed whether the camera can visualize the primary lesion, including heterogeneity and lymph nodes will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure image quality of the 1 mm resolution PET imaging device</measure>
    <time_frame>Day 1</time_frame>
    <description>Image quality of the 1 mm resolution PET imaging device (scale 1-5) with 5 being highest 'image quality' will be assessed to understand radioactive dose and scan time required for a given desired image quality.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Novel PET Camera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients already undergoing a PET/CT scan for HNC will afterwards undergo a PET scan with the proposed device, thus no additional radioactivity is needed as part of this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1-mm Resolution Clinical PET camera</intervention_name>
    <description>1-Millimeter Resolution Clinical PET System in Head and Neck Cancer (HNC) Imaging</description>
    <arm_group_label>Novel PET Camera</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Biopsy-confirmed diagnosis of HNC&#xD;
&#xD;
          2. Patient scheduled to undergo surgery for HNC&#xD;
&#xD;
          3. Scheduled to have a PET/CT study on a conventional PET/CT system&#xD;
&#xD;
          4. Age greater than or equal to 19 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Additional condition, or extenuating circumstance that, in the opinion of the&#xD;
        investigator, may interfere with study compliance.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eben Rosenthal, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford Universiy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grace Yi</last_name>
    <phone>650-242-2666</phone>
    <email>gracesyi@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Grace Yi</last_name>
      <phone>650-723-4467</phone>
      <email>gracesyi@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Eben Rosenthal, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 6, 2020</study_first_submitted>
  <study_first_submitted_qc>December 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

